2,4-thiazolidinedione

Generic Name
2,4-thiazolidinedione
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C3H3NO2S
CAS Number
2295-31-0
Unique Ingredient Identifier
AA68LXK93C
Background

Thiazolidinedione has been investigated for the treatment of Type 2 Diabetes, Diabetes Mellitus, and DIABETES MELLITUS, TYPE 2.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

First Posted Date
2013-01-28
Last Posted Date
2017-05-03
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
374
Registration Number
NCT01777282
Locations
🇯🇵

GSK Investigational Site, Tokyo, Japan

Integrating the Genetic and Metabolic Faces of Obesity

First Posted Date
2006-02-02
Last Posted Date
2024-12-04
Lead Sponsor
Stanford University
Target Recruit Count
88
Registration Number
NCT00285844
Locations
🇺🇸

Stanford University, Stanford, California, United States

Islet Transplantation in Type 1 Diabetic Patients

Phase 1
Completed
Conditions
Type 1 Diabetes
Interventions
Drug: Thiazolidinedione
First Posted Date
2005-09-21
Last Posted Date
2017-03-31
Lead Sponsor
University of Wisconsin, Madison
Target Recruit Count
14
Registration Number
NCT00214253
Locations
🇺🇸

University of Wisconsin, Madison, Wisconsin, United States

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

Phase 3
Completed
Conditions
Diabetes Mellitus
First Posted Date
2002-10-02
Last Posted Date
2011-01-11
Lead Sponsor
Sanofi
Target Recruit Count
240
Registration Number
NCT00046462
Locations
🇺🇸

Aventis, Bridgewater, New Jersey, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy